Year: 2011

A Randomized, Double Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or At High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxen and Ibuprofen.

Sponsor:
Pfizer
CRO:
Quintiles
Study ID:
A3191172
Phase:
N/A